Comparative Immunology of Tuberculosis Ray Waters, DVM, PhD Tuberculosis Research Project National Animal Disease Center Ames, Iowa.

Slides:



Advertisements
Similar presentations
The life history of T lymphocytes
Advertisements

Cell-Mediated Effector Responses Chapter 14
Development of Vaccine Approaches for Bovine Tuberculosis in Free- Ranging White-tailed Deer Mitchell Palmer, Ray Waters, Tyler Thacker National Animal.
Acquired Immune Response Sanjaya Adikari Department of Anatomy.
Cell Mediated Immunity (CMI) Immune team. Cell-Mediated Immunity (CMI) Antigen T-lymphocytes Immune responses Immune responses.
Immunology of Tuberculosis
Defenses Against Infection 1. Innate responses (humoral and cellular) 2. Immunity to intracellular pathogens NK cells, control of Th1/Th2 responses 3.
Lecture outline The nomenclature of Immunology Types of immunity (innate and adaptive; active and passive; humoral and cell- mediated) Features of immune.
Lecture outline The nomenclature of Immunology
Lecture 11-Activation of naïve T cells Naïve T cells are activated in lymph nodes and spleen. Dendritic cells are key antigen presenting cells for naïve.
T cells Jan Novák. The immune system Protection against infectious agents Clearance of dying, damaged and dangerous cells Regulation of the immune responses.
Microbiology 204: Cellular and Molecular Immunology Class meets MWF 11-12:30 Lectures are open to auditors Discussions are restricted to those enrolled.
Introduction to immunology Jan. 19 Reading: Chapter 1.
Immunology of HPV Infection Craig Woodworth Department of Biology Clarkson University Potsdam, NY.
Cell Mediated Immunity (CMI) Prof. Dr. Zahid Shakoor MBBS, Ph D (London) College of Medicine King Saud University.
Immunology of Vaccines
Julio A. Ramirez, MD, FACP Professor of Medicine Chief, Infectious Diseases University of Louisville Chief, Infectious Diseases Veterans Affairs Medical.
Imtiaz Khan Professor Dept. of Microbiology, Immunology and Tropical Medicine
Human M. tuberculosis infection/ disease: classical pathology and immunology (Slide -1) W. Henry Boom, M.D. Tuberculosis Research Unit (TBRU) Case Western.
The life history of T lymphocytes Precursors mature in the thymus Naïve CD4+ and CD8+ T cells enter the circulation Naïve T cells circulate through lymph.
Mast cell-orchestrated immunity to pathogens Soman N. Abraham and Ashley L. St. John Nature Reviews Immunology June 2010.
Immunity to Infection 101: A superficial overview For the full story, signup for CBIO 4100/6100 Fall and Spring semesters.
Preclinical evaluation of safety, efficacy, immunogenicity of a recombinant rBCG Pasteur B vaccine Group B4 March 16, 2011 Adane Miheret, Tewodros Tariku.
Immunology molecular medicine 3 Conleth Feighery.
Cell Mediated Immunity (CMI)
MICR 304 Immunology & Serology Lecture 6 NK Cells, Lymphocytes Chapter 1.4 –1.17; 2.30 – 2.33 Lecture 6 NK Cells, Lymphocytes Chapter 1.4 –1.17; 2.30 –
Immunology of tuberculosis .
TYPE III & IV HYPERSENSITIVITY REACTION 1 Hypersensitivity reaction.
Copyright © 2006 Pearson Education, Inc., publishing as Benjamin Cummings PowerPoint ® Lecture Slide Presentation prepared by Christine L. Case M I C R.
Cell Mediated Immunity
Immune System Chapter 43. Types of Invaders _________: a bacterium, fungus, virus, or other disease causing agent  Antigen: any foreign molecule or protein.
Chapter 16 Immunity to Microbes.
Chapter 10. Cell-mediated immunity (CMI) is the type of host defense that is mediated by T lymphocytes, and it serves as a defense mechanism against.
Effector T Cell Subsets, Cytokines
Human M. tuberculosis infection/ disease: classical pathology and immunology (Slide -1) W. Henry Boom, M.D. Tuberculosis Research Unit (TBRU) Case Western.
Chapter 43 Warm-Up Define the following terms:
Tuberculosis.
16 Adaptive Immunity.
CATEGORY: PATHOGENS & DISEASE
Human Cytomegalovirus (HCMV)
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
Immunology Essentials Introduction to Innate and Adaptive Immunity
Immune System Basics Immunity: The capacity to resist infectious pathogens. Pathogens: Disease-causing organisms Self vs. Non-self recognition Major Histocompatibility.
Scientific Challenges for the Development of an HIV Vaccine
Thymocyte development summary
Cell Mediated Immunity
Adaptive Immune Response (Cell Mediated Immunity)
Innate microbial sensors and their relevance to allergy
Avoiding Immune Detection
Immunological memory Topics Immune regulation  T cells
A Clinical Trial to Demonstrate the Safety and Efficacy of H56:IC31 for the Prevention of Tuberculosis Infection TBVI Annual meeting, Les Diablerets 2018.
Humoral & Cell-mediated immunity
Malaria Vaccine Design: Immunological Considerations
Minyoung Her, MD, Arthur Kavanaugh, MD 
Stefan H.E. Kaufmann, Shreemanta K. Parida  Cell Host & Microbe 
Critical research concepts in tuberculosis vaccine development
Potential role for mucosally active vaccines against pneumococcal pneumonia  Kondwani C. Jambo, Enoch Sepako, Robert S. Heyderman, Stephen B. Gordon  Trends.
Immune Complex as Vaccine against Tuberculosis
Respiratory syncytial virus (RSV) infection and the host.
IMMUNE RESPONSE TO MYCOBACTERIAL INFECTION
Humoral and Cell Mediated Immunity
Volume 33, Issue 4, Pages (October 2010)
Cell Mediated Immunity
A View to Natural Killer Cells in Hepatitis C
Stefan H.E. Kaufmann, Shreemanta K. Parida  Cell Host & Microbe 
Th1 and Th2 immune responses
Immunology of Tuberculosis Department of Pathology
Immunology of Tuberculosis Department of Pathology
Vaccines for Lung Cancer
Presentation transcript:

Comparative Immunology of Tuberculosis Ray Waters, DVM, PhD Tuberculosis Research Project National Animal Disease Center Ames, Iowa

Immune Response - Relevance 1. Diagnostics: Is the animal infected? 2. Vaccination: Did the vaccine elicit a response and is this response protective? 3. Correlations to: Pathology: response after infection compared to disease Protection: response after vaccination compared to efficacy Infection: Active vs latent? Progressive, resolving, or cured? Robert Koch, develops tuberculin

Immune Response – One Size Does Not Fit All! Host Factors: Poorly organized vs organized granulomas, badgers vs cattle Multibacillary vs paucibacillary disease, mice vs humans/cattle Pathogen Factors: M. bovis, M. tuberculosis, M. africanum, M. caprae, M. pinnipedii, M. mungi, M. microti, dassie bacillus, etc Hopkins Model - Cavitation in rabbits upon M. tb challenge requires prior sensitization to heat killed M. bovis Host / Pathogen Interactions: Host adaptation led to speciation Speciation partially defined by transmission capacity Environmental Factors: M. mungi – prevalence dramatically increases with dry season / Badgers and underground environment Nutrition, exposure, over-population, stress, etc. Louis Pasteur ’s, germ theory of tuberculosis & pasteurization

Humans IFN-  : humans with defective receptors develop severe disease TNF-  : essential for proper granuloma formation – TNF inhibitors used for Crohns Disease, rheumatoid arthritis, etc. promote transition from latent to active TB CD4+ cells: HIV patients more susceptible IL-12: humans with defective IL12p40 subunit or receptors develop severe disease Antibody: associated with active disease; sensitivity associated with smear positive cases which correlate with pathology – likely due to antigen load Latent disease common – latency not documented in other species! Generally only CMI (undetectable antibody) with latent disease. Chemokines, Cathelicidins, CD8+ cells, IL-17, etc. Emil von Behring Nobel Prize, 1901 Also, M. tb to cattle “I need hardly add that the fight against cattle tuberculosis only marks a stage on the road which leads finally to the effective protection of human beings against the disease.”

Laboratory Models of TB Mice: multibacillary, high mycobacterial burden with progressive, less- organized pathology and more neutrophils than many other species IFN-  > NO >  TCR > MHC II > MHC I > WT and  TCR - Th1 immunity crucial Kinetics of Infection: 2 wk delay in activation of T cells, optimal antigen presentation in lymph nodes draining the lungs, then migration of specific T cells back to the lungs Apoptosis of infected macrophages critical for efficient priming of T cells via uptake of apoptotic vesicles and antigen presentation by dendritic cells - M. tb complex mycobacteria actively inhibit apoptosis Guinea Pigs, Rabbits: pathology similar to humans, models for evaluating DTH and cellular immunity to TB Skin test in Mice – sensitivity to tuberculin 1000X lower than humans (differences exist in application of diagnostic tests)

Hosts of Veterinary Significance Cattle: DTH, IFN-  (Bovigam), poor antibody response, Cervids: DTH (? Accuracy), moderate antibody response Eurasian Badgers: Poor DTH response, antibody to MPB83 correlates w/bacterial load & ability to transmit, pathology – poor granuloma, cell- mediated immunity less vigorous yet good enough (low EC response) Elephants: Robust antibody response, poor DTH (difficult to apply) South American Camelids: antibody response, poor DTH Wildboar, Spain: Oral heat-killed M. bovis vaccine is effective? Antigen recognition profiles vary for different species Pulsar.Two-worlds.com

Correlates of Protection (the Holy Grail) DTH (skin test) is indicative of prior exposure to Mycobacteria spp. but is NOT indicative of disease severity or protection elicited by vaccination IFN-  responses, especially to specific antigens such as ESAT- 6/CFP10, are indicative of infection but do not necessarily correlate to protection elicited by vaccination Central Memory Responses (TcM) – correlate to reduced bacterial burden and reduced pathology IL-17 – correlate to pathology, pre-challenge responses may also correlate to protection. Multi-functional T cells - IFN-  TNF- , IL-2 Patterns of response (multi cytokine / chemokine / etc. profile) – outcome of RNA sequencing studies Leonard Pearson st injection of tuberculin to US cattle for TB test

Cattle IFN-  Response - Diagnostic and Correlate to Infection ESAT-6:CFP10 response generally correlates to Pathology

* * * * * * Cattle The IFN-  Response to PPDb does not always Correlate to Pathology; however, it is a good Correlate to Infection

A B WCS MPB _ MW (kDa) Days Post-inoculation -7 _ Early and sustained antibody response MPB83 WCS

non-inf. Immunoblot M. tuberculosis culture isolated, treatment initiated

Conclusions: Comparative Immunology to TB Similar, yet different, immune responses between hosts / pathogens Opportunities: 1. TcM 2. Specific antibody 3. Cytokine profile comparisons 4. Host / pathogen comparisons 5. Interactions 6. Field Application In regards to the immune response to TB, generalizations and extrapolations between hosts is risky!!!